What is the Fiscal Year for Lexaria Bioscience?
Date: November 15, 2026
Lexaria Bioscience's current fiscal year starts on September 1, 2026, and ends on August 31, 2027. Their current quarter is Q1, which ends on November 30, 2026.
Current Fiscal Year Overview
Fiscal Year Start
September 1, 2026
Fiscal Year End
August 31, 2027
Current Quarter
Q1
Current Quarter End
November 30, 2026
Quarterly Breakdown
Q1
Sep 1, 2026 – Nov 30, 2026
Q2
Dec 1, 2026 – Feb 28, 2027
Q3
Mar 1, 2027 – May 31, 2027
Q4
Jun 1, 2027 – Aug 31, 2027
Company Information
Headquarters
Kelowna, British Columbia, Canada
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
LEXX
Description
DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide. For more information, please visit www.lexariabioscience.com.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Lexaria Bioscience and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.